Rimonabantacid
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid
CAS: 162758-35-2
Molecular Formula: C17H11Cl3N2O2
Rimonabantacid - Names and Identifiers
Rimonabantacid - Physico-chemical Properties
| Molecular Formula | C17H11Cl3N2O2 |
| Molar Mass | 381.64 |
| Density | 1.48 |
| Melting Point | 202-203 °C |
| Boling Point | 551.2±50.0 °C(Predicted) |
| Flash Point | 287.2°C |
| Solubility | DMSO (Slightly), Methanol (Slightly, Heated) |
| Vapor Presure | 5.52E-13mmHg at 25°C |
| Appearance | Solid |
| Color | White |
| pKa | 3.33±0.34(Predicted) |
| Storage Condition | 2-8°C |
| Refractive Index | 1.663 |
Rimonabantacid - Risk and Safety
| Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
| Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
| HS Code | 29339900 |
Rimonabantacid - Reference Information
| rimonabant carboxylic acid | rimonabant carboxylic acid is a white to off-white crystalline powder at room temperature, it is mainly used for the synthesis of the most promising weight loss drug rimonabant in the world. Rimonabant, a weight-loss drug, was developed by a French company Sanofi-Aventis and is the first cannabinoid type 1 receptor (CB1) antagonist to be used in the treatment of obesity, by selectively blocking the cannabinoid-1(cannabinoid-1,CB1) receptor in the EC system, it can significantly reduce body weight, reduce waist circumference, reduce risk factors such as cardiovascular disease, it can also improve blood lipid and insulin resistance, metabolic syndrome and the like, and is particularly suitable for people at risk of clinical obesity or heart disease. |
Last Update：2024-04-09 19:05:08
